A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib
- Status
- COMPLETED
- Phase
- N/A
Study of Select Combinations in Adults With Myelofibrosis
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)
- Status
- TERMINATED
- Phase
- PHASE3
Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
- Status
- TERMINATED
- Phase
- PHASE1
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)
- Status
- TERMINATED
- Phase
- PHASE3
Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).
- Status
- COMPLETED
- Phase
- PHASE4
Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab
- Status
- TERMINATED
- Phase
- PHASE3
Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Investigating the Effects of QVM149 on MRI Ventilation Defects
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
- Status
- TERMINATED
- Phase
- PHASE3